Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $113
Benzinga Newsdesk 10 hours ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $113.
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $113.